Syngenta collaborates with Maxygen to optimize molecular enabling technology
US biotech, Maxygen, which specializes in the directed evolution of proteins, is collaborating with Syngenta Seeds to optimize its enabling technologies.
Since the collaboration launched, one of the success factors has been the consistent and robust level of scientific engagement on both sides. Both Maxygen and Syngenta adopted an open collegiate approach from the start, with Syngenta giving the collaboration a high-priority status as part of its core portfolio, enabling the project to progress swiftly.
The teams from Syngenta and Maxygen met frequently to review results, manage decision-making, adjust plans, and mark progress milestones. This approach has delivered success resulting in protein variants with highly improved attributes and the subject of novel intellectual property.
“We’re looking forward to connecting with new partners from academia, research institutes, start-ups, and cross-industry sectors, to work with our extensive global network of scientists and to push the boundaries of what is known today in science,” said Camilla Corsi, Syngenta’s Global Head of Crop Protection Research. “We’re proud of our strong reputation as a collaborator of choice and are excited about the potential of the Shoots by Syngenta platform to generate new possibilities to benefit farmers and agriculture.”
Image: Getty/ Mindful Media
